Hi io_io, your analysis of the recent conference was excellent.
I just listened to the Rodman & Renshaw presentation on 9/11/09 a few minutes ago and was impressed by Neil Warma.
Correct me if I heard wrong, but the confirmatory IIb future 200 patient clinical trial is expected to begin in the 2nd half of 2010 and only after partnering. He similarly expected partnering in the 2nd half of 2010. Do you think an announcement will come earlier? They received 3 million upfront from Novartis on the stem cell agreement with another 1 million in technology transfer payments over six months. The June 2009 10Q indicates a burn rate of 250,000 per month so liquidity and going concern issues should not be a problem. I too would not be surprised at a small opportunistic financing. How do you see this investment working out considering the long path ahead? Going from 9 cents to 4 dollars in one year was pretty amazing.
Market Data 
Markets 
AI
